O

Onconetix Inc
D

ONCO

0.66980
USD
-0.05
(-6.96%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
2,645,112
المقالات
المزيد

العنوان: Onconetix Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.